Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-02-25 @ 7:22 PM
Study NCT ID:
NCT00655551
Status:
COMPLETED
Last Update Posted:
2018-07-17
First Post:
2008-03-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
Sponsor:
UCB BIOSCIENCES, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP0925
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None